Surmodics Operating Expenses 2011-2026 | SRDX

Annual Operating Expenses Surmodics

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	26.4 M	26.6 M	22.9 M	20.4 M	18 M	15.3 M	13.9 M	28.2 M	51.2 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
51.2 M	13.9 M	24.8 M

Operating Expenses of other stocks in the Diagnostics research industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	58 M	-	-6.23 %	$ 30.6 M	Germany
Aspira Women's Health AWH	13.8 M	-	-6.19 %	$ 10.5 M	USA
Agilent Technologies A	1.99 B	$ 116.92	2.67 %	$ 35.5 B	USA
Biocept BIOC	21.6 M	-	-13.05 %	$ 7.29 M	USA
DermTech DMTK	104 M	-	-11.32 %	$ 2.94 M	USA
BioNano Genomics BNGO	41.3 M	$ 1.18	0.85 %	$ 6.43 M	USA
Enzo Biochem ENZ	47.4 M	-	-8.98 %	$ 14.8 K	USA
Exact Sciences Corporation EXAS	2.47 B	-	-	$ 19.8 B	USA
Interpace Biosciences IDXG	20 M	$ 1.98	-0.63 %	$ 8.76 M	USA
CareDx, Inc CDNA	411 M	$ 17.92	1.41 %	$ 955 M	USA
Oxford Immunotec Global PLC OXFD	59.4 M	-	-	$ 562 M	Britain
Akumin AKU	778 M	-	-17.87 %	$ 25.9 M	Canada
Heska Corporation HSKA	131 M	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	24.1 M	-	-20.0 %	$ 1.06 M	USA
Burning Rock Biotech Limited BNR	726 M	$ 16.24	0.93 %	$ 175 M	China
Co-Diagnostics CODX	50.6 M	$ 4.4	101.83 %	$ 5.85 M	USA
Accelerate Diagnostics AXDX	77.2 M	-	-61.36 %	$ 2.46 M	USA
Castle Biosciences CSTL	59.5 M	$ 25.19	1.45 %	$ 700 M	USA
Global Cord Blood Corporation CO	451 M	-	-	$ 399 M	China
Fluidigm Corporation FLDM	134 M	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	5.91 M	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	983 M	-	0.12 %	$ 80.1 M	China
Charles River Laboratories International CRL	607 M	$ 175.07	3.26 %	$ 8.68 B	USA
PRA Health Sciences, Inc. PRAH	585 M	-	-	$ 10.7 B	USA
Motus GI Holdings MOTS	18.6 M	-	-34.28 %	$ 263 K	Israel
Danaher Corporation DHR	6.71 B	$ 196.19	2.71 %	$ 140 B	USA
OpGen OPGN	21.9 M	-	-16.95 %	$ 1.54 M	USA
PerkinElmer PKI	1.07 B	-	-0.91 %	$ 14.7 B	USA
Twist Bioscience Corporation TWST	116 M	$ 51.17	2.09 %	$ 3.06 B	USA
Fulgent Genetics FLGT	181 M	$ 15.83	-0.5 %	$ 479 M	USA
Quotient Limited QTNT	106 M	-	-11.32 %	$ 1.1 M	Schweiz
Guardant Health GH	226 M	$ 92.84	-0.49 %	$ 11.6 B	USA
QIAGEN N.V. QGEN	821 M	-	-	$ 10.6 B	Niderland
Anixa Biosciences ANIX	9.98 M	$ 2.73	1.49 %	$ 88.6 K	USA
Biomerica BMRA	5.64 M	$ 2.15	-0.46 %	$ 4.94 M	USA
ICON Public Limited Company ICLR	408 M	$ 106.54	-0.58 %	$ 8.79 B	Irlanda
Check-Cap Ltd. CHEK	14.1 M	-	-	$ 9.42 M	Israel
Illumina ILMN	3.69 B	$ 128.0	1.23 %	$ 20.4 B	USA
Celcuity CELC	172 M	$ 116.94	1.19 %	$ 5.47 B	USA
Laboratory Corporation of America Holdings LH	1.87 B	$ 274.72	2.06 %	$ 22.9 B	USA
Lantheus Holdings LNTH	123 M	$ 80.03	2.5 %	$ 5.4 B	USA
Medpace Holdings MEDP	118 M	$ 520.65	2.39 %	$ 15 B	USA
Chembio Diagnostics CEMI	28.5 M	-	0.22 %	$ 16.8 M	USA
Quest Diagnostics Incorporated DGX	1.46 B	$ 198.81	1.02 %	$ 22.1 B	USA
Myriad Genetics MYGN	964 M	$ 4.77	0.63 %	$ 442 M	USA
NeoGenomics NEO	430 M	$ 8.22	1.99 %	$ 1.05 B	USA
Neogen Corporation NEOG	1.48 B	$ 10.34	3.61 %	$ 2.24 B	USA
ENDRA Life Sciences NDRA	5.76 M	$ 5.17	-3.18 %	$ 4.07 M	USA
National Research Corporation NRC	38.5 M	$ 17.26	1.29 %	$ 386 M	USA
Natera NTRA	258 M	$ 210.83	0.75 %	$ 20.7 B	USA